SARS-CoV-2 EPIDEMICS AND DIABETES

  • Cristian Guja

Abstract

An editorial related to the recent SARS-CoV-2 ep- idemics in a diabetes/metabolism journal might seem strange. However, the implications for diabetes sub- jects, usually defined as a vulnerable population in this respect, make worth this endeavor. Moreover, the SARS-CoV-2 epidemic comes on top of the long-time recognized “diabetes epidemic” that does not show signs of relenting. Thus, the latest International Dia- betes Federation (IDF) data show that 463 million peo- ple are affected worldwide, an increase of 38 million compared to 2017. In addition, total healthcare costs associated with diabetes are estimated to around 760 billion USD

Published
2020-03-15
How to Cite
Guja, Cristian. 2020. “SARS-CoV-2 EPIDEMICS AND DIABETES”. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 27 (1), 1-3. http://www.rjdnmd.org/index.php/RJDNMD/article/view/747.
Section
Editorials